Copenhagen, Denmark

Lisbeth Hedegangrd

This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Lisbeth Hedegangrd

Introduction

Lisbeth Hedegangrd is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biochemistry, particularly in the development of stabilized enzymes and detergent compositions. Her innovative work has garnered attention in both academic and industrial circles.

Latest Patents

Lisbeth holds a patent for her invention related to stabilized enzymes and detergent compositions. This patent showcases her ability to create effective solutions that enhance the performance of cleaning products. She has been recognized for her unique approach to enzyme stabilization, which has practical applications in various industries.

Career Highlights

Lisbeth is currently employed at Novo Nordisk A/S, a leading global healthcare company. Her role at Novo Nordisk allows her to apply her expertise in enzyme technology to develop innovative products that improve patient care. With her background in biochemistry, she has become an integral part of the research and development team.

Collaborations

Throughout her career, Lisbeth has collaborated with notable colleagues, including Claus Von Der Osten and Sven Branner. These partnerships have fostered a creative environment that encourages the exchange of ideas and the advancement of scientific knowledge.

Conclusion

Lisbeth Hedegangrd's contributions to the field of biochemistry and her innovative patent demonstrate her commitment to advancing technology in the healthcare sector. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…